Article
The efficacy and safety of ipilimumab (MDX-010) in patients with unresectable stage III or stage IV malignant melanoma
Journal of Clinical Oncology
(2007)
Disciplines
Publication Date
June 20, 2007
Citation Information
J. S. Weber, E. M. Hersh, M. Yellin, G. M. Nichol, et al.. "The efficacy and safety of ipilimumab (MDX-010) in patients with unresectable stage III or stage IV malignant melanoma" Journal of Clinical Oncology Vol. 25 (2007) p. 8523 Available at: http://works.bepress.com/walter-urba/179/